BioStem Technologies Third Quarter 2024 Report
Today, November 12, 2024, BioStem Technologies (BSEM), a leading MedTech company focused on developing, manufacturing, and commercializing placental-derived biologics, reported financial results for the third quarter ended September 30, 2024. The Company will host a webcast and conference call on Tuesday, November 12, 2024, at 4:30 pm ET.
From BioStem Technologies
Jason Matuszewski, CEO of . . .
This content is for paid subscribers.
Today’s Highlights
November 12, 2024
